Relationship between posttransplantation LSC-based MRD assay or traditional assay detected by MFC and transplant outcomes for patients with AML who underwent allo-SCT (n = 360). Competing risk model and Kaplan-Meier estimates of relapse and LFS, respectively, according to posttransplantation CD34⁺CD38⁻cocktail⁺ LSCs (A-B), posttransplant CD34⁺CD38⁻cocktail⁺/CD33⁺/CD45RA⁺ LSCs (C-D), and posttransplantation traditional MRD (E-F). allo-SCT, allogeneic stem cell transplantation; neg, negative; pos, positive.